Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI106801

Quantitative Determination of the Human Immune Response to Immunization with Meningococcal Vaccines

Emil C. Gotschlich, Michel Rey, Rene Triau, and Kenneth J. Sparks

Rockefeller University, New York 10021

Faculte Mixte de Medicine et de Pharmacie, Dakar, Senegal

Institut Merieux, Lyon, France

Find articles by Gotschlich, E. in: PubMed | Google Scholar

Rockefeller University, New York 10021

Faculte Mixte de Medicine et de Pharmacie, Dakar, Senegal

Institut Merieux, Lyon, France

Find articles by Rey, M. in: PubMed | Google Scholar

Rockefeller University, New York 10021

Faculte Mixte de Medicine et de Pharmacie, Dakar, Senegal

Institut Merieux, Lyon, France

Find articles by Triau, R. in: PubMed | Google Scholar

Rockefeller University, New York 10021

Faculte Mixte de Medicine et de Pharmacie, Dakar, Senegal

Institut Merieux, Lyon, France

Find articles by Sparks, K. in: PubMed | Google Scholar

Published January 1, 1972 - More info

Published in Volume 51, Issue 1 on January 1, 1972
J Clin Invest. 1972;51(1):89–96. https://doi.org/10.1172/JCI106801.
© 1972 The American Society for Clinical Investigation
Published January 1, 1972 - Version history
View PDF
Abstract

Radioactive antigen binding tests have been developed to measure quantitatively the antibody response of 167 adults, 84 children, and 51 infants to several different preparations of group A and group C meningococcal polysaccharides. Almost all the adults injected responded and the geometric mean responses were approximately 15 μg/ml of antibody protein in individuals vaccinated subcutaneously with two preparations of group A vaccine. The geometric mean antibody concentration after immunization with two preparations of group C vaccine was approximately 35 μg/ml. Most children aged 7 yr responded to immunization with two group A vaccines, and their mean response was only slightly less than that seen in adults. There was no difference between the subcutaneous and the intradermal route if both were given with jet gun. The majority of infants aged 6-13 months responded to a preparation of group A vaccine and the geometric mean titer was approximately 1.2 μg/ml. Adults, children, and infants responded significantly less to a preparation of group A polysaccharide which was of low molceular weight.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 89
page 89
icon of scanned page 90
page 90
icon of scanned page 91
page 91
icon of scanned page 92
page 92
icon of scanned page 93
page 93
icon of scanned page 94
page 94
icon of scanned page 95
page 95
icon of scanned page 96
page 96
Version history
  • Version 1 (January 1, 1972): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts